Banks - Regional
Compare Stocks
4 / 10Stock Comparison
BCH vs BMA vs BSAC vs GGAL
Revenue, margins, valuation, and 5-year total return — side by side.
Banks - Regional
Banks - Regional
Banks - Regional
BCH vs BMA vs BSAC vs GGAL — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Banks - Regional | Banks - Regional | Banks - Regional | Banks - Regional |
| Market Cap | $18.40B | $4.70B | $14.38B | $5.73B |
| Revenue (TTM) | $2.64T | $6.46T | $4.66T | $10.63T |
| Net Income (TTM) | $1.19T | $291.41B | $1.05T | $915.98B |
| Gross Margin | 100.0% | 68.3% | 48.8% | 62.7% |
| Operating Margin | 100.0% | 5.6% | 26.7% | 20.8% |
| Forward P/E | 0.0x | 0.0x | 0.0x | 0.0x |
| Total Debt | $14.00T | $465.41B | $15.88T | $2.16T |
| Cash & Equiv. | $2.59T | $2.78T | $5.24T | $3.76T |
BCH vs BMA vs BSAC vs GGAL — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Banco de Chile (BCH) | 100 | 220.3 | +120.3% |
| Banco Macro S.A. (BMA) | 100 | 436.3 | +336.3% |
| Banco Santander-Chi… (BSAC) | 100 | 193.6 | +93.6% |
| Grupo Financiero Ga… (GGAL) | 100 | 539.8 | +439.8% |
Price return only. Dividends and distributions are not included.
Quick Verdict: BCH vs BMA vs BSAC vs GGAL
Each card shows where this stock fits in a portfolio — not just who wins on paper.
BCH is the clearest fit if your priority is long-term compounding.
- 154.4% 10Y total return vs GGAL's 71.6%
BMA lags the leaders in this set but could rank higher in a more targeted comparison.
BSAC carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 1 yrs, beta 0.94, yield 100.0%
- Rev growth -5.0%, EPS growth 492.6%
- Beta 0.94, yield 100.0%, current ratio 0.21x
- -5.0% NII/revenue growth vs BCH's -43.1%
GGAL is the #2 pick in this set and the best alternative if sleep-well-at-night and valuation efficiency is your priority.
- Lower volatility, beta 1.73, Low D/E 35.6%, current ratio 0.66x
- PEG 0.00 vs BCH's 0.00
- NIM 15.8% vs BSAC's 2.9%
- Lower P/E (0.0x vs 0.0x), PEG 0.00 vs 0.00
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | -5.0% NII/revenue growth vs BCH's -43.1% | |
| Value | Lower P/E (0.0x vs 0.0x), PEG 0.00 vs 0.00 | |
| Quality / Margins | Efficiency ratio 0.2% vs BMA's 0.6% (lower = leaner) | |
| Stability / Safety | Beta 0.94 vs BMA's 1.76 | |
| Dividends | 100.0% yield, 1-year raise streak, vs BMA's 7.0% | |
| Momentum (1Y) | +32.8% vs GGAL's -23.2% | |
| Efficiency (ROA) | Efficiency ratio 0.2% vs BMA's 0.6% |
BCH vs BMA vs BSAC vs GGAL — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Segment breakdown not available.
Segment breakdown not available.
BCH vs BMA vs BSAC vs GGAL — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
BMA leads in 2 of 6 categories
BSAC leads 2 • BCH leads 1 • GGAL leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
BCH leads this category, winning 4 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
GGAL is the larger business by revenue, generating $10.63T annually — 4.0x BCH's $2.64T. BCH is the more profitable business, keeping 45.1% of every revenue dollar as net income compared to BMA's 5.0%.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $2.64T | $6.46T | $4.66T | $10.63T |
| EBITDAEarnings before interest/tax | $1.57T | $620.9B | $1.45T | $1.35T |
| Net IncomeAfter-tax profit | $1.19T | $291.4B | $1.05T | $916.0B |
| Free Cash FlowCash after capex | -$436.7B | -$2.44T | $776.1B | $3.62T |
| Gross MarginGross profit ÷ Revenue | +100.0% | +68.3% | +48.8% | +62.7% |
| Operating MarginEBIT ÷ Revenue | +100.0% | +5.6% | +26.7% | +20.8% |
| Net MarginNet income ÷ Revenue | +45.1% | +5.0% | +21.9% | +15.3% |
| FCF MarginFCF ÷ Revenue | +16.7% | +12.3% | +13.4% | -27.4% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | -10.8% | -136.4% | -8.2% | -138.6% |
Valuation Metrics
Evenly matched — BSAC and GGAL each lead in 3 of 7 comparable metrics.
Valuation Metrics
At 0.0x trailing earnings, BSAC trades at a 100% valuation discount to BMA's 20.4x P/E. Adjusting for growth (PEG ratio), BSAC offers better value at 0.00x vs BCH's 0.57x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $18.4B | $4.7B | $14.4B | $5.7B |
| Enterprise ValueMkt cap + debt − cash | $31.1B | $3.0B | $26.3B | $4.6B |
| Trailing P/EPrice ÷ TTM EPS | 13.83x | 20.42x | 0.03x | 5.06x |
| Forward P/EPrice ÷ next-FY EPS est. | 0.01x | 0.01x | 0.01x | 0.01x |
| PEG RatioP/E ÷ EPS growth rate | 0.57x | 0.40x | 0.00x | 0.04x |
| EV / EBITDAEnterprise value multiple | 19.42x | 8.47x | 17.04x | 2.65x |
| Price / SalesMarket cap ÷ Revenue | 6.24x | 1.01x | 2.77x | 0.75x |
| Price / BookPrice ÷ Book value/share | 2.84x | 1.64x | 0.03x | 1.47x |
| Price / FCFMarket cap ÷ FCF | 37.39x | 8.22x | 20.64x | — |
Profitability & Efficiency
BMA leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
BSAC delivers a 21.5% return on equity — every $100 of shareholder capital generates $22 in annual profit, vs $6 for BMA. BMA carries lower financial leverage with a 0.11x debt-to-equity ratio, signaling a more conservative balance sheet compared to BSAC's 2.77x. On the Piotroski fundamental quality scale (0–9), BMA scores 6/9 vs GGAL's 3/9, reflecting solid financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +20.6% | +6.1% | +21.5% | +12.9% |
| ROA (TTM)Return on assets | +2.2% | +1.4% | +1.6% | +2.2% |
| ROICReturn on invested capital | +10.3% | +5.5% | +4.5% | +31.0% |
| ROCEReturn on capital employed | +9.7% | +5.5% | +3.4% | +19.5% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 6 | 5 | 3 |
| Debt / EquityFinancial leverage | 2.41x | 0.11x | 2.77x | 0.36x |
| Net DebtTotal debt minus cash | -$1.50T | -$2.31T | $10.64T | -$203.1B |
| Cash & Equiv.Liquid assets | $2.59T | $2.78T | $5.24T | $3.76T |
| Total DebtShort + long-term debt | $14.00T | $465.4B | $15.88T | $2.16T |
| Interest CoverageEBIT ÷ Interest expense | 2.04x | 0.28x | 0.72x | 0.71x |
Total Returns (Dividends Reinvested)
BMA leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in BMA five years ago would be worth $62,073 today (with dividends reinvested), compared to $15,452 for BSAC. Over the past 12 months, BSAC leads with a +32.8% total return vs GGAL's -23.2%. The 3-year compound annual growth rate (CAGR) favors BMA at 69.4% vs BSAC's 20.4% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | -0.3% | -13.9% | +2.7% | -18.1% |
| 1-Year ReturnPast 12 months | +24.7% | -9.1% | +32.8% | -23.2% |
| 3-Year ReturnCumulative with dividends | +86.5% | +386.0% | +74.3% | +304.2% |
| 5-Year ReturnCumulative with dividends | +97.3% | +520.7% | +54.5% | +517.5% |
| 10-Year ReturnCumulative with dividends | +154.4% | +48.5% | +125.2% | +71.6% |
| CAGR (3Y)Annualised 3-year return | +23.1% | +69.4% | +20.4% | +59.3% |
Risk & Volatility
BSAC leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
BSAC is the less volatile stock with a 0.94 beta — it tends to amplify market swings less than BMA's 1.76 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. BSAC currently trades 80.9% from its 52-week high vs GGAL's 66.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.95x | 1.76x | 0.94x | 1.73x |
| 52-Week HighHighest price in past year | $46.77 | $106.15 | $37.72 | $65.48 |
| 52-Week LowLowest price in past year | $27.08 | $38.30 | $22.77 | $25.89 |
| % of 52W HighCurrent price vs 52-week peak | +77.9% | +70.5% | +80.9% | +66.0% |
| RSI (14)Momentum oscillator 0–100 | 47.7 | 53.1 | 40.3 | 46.5 |
| Avg Volume (50D)Average daily shares traded | 404K | 366K | 453K | 1.1M |
Analyst Outlook
BSAC leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: BCH as "Buy", BMA as "Buy", BSAC as "Hold", GGAL as "Buy". Consensus price targets imply 73.6% upside for BMA (target: $130) vs 9.7% for BSAC (target: $34). For income investors, BSAC offers the higher dividend yield at 100.00% vs BCH's 5.74%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Hold | Buy |
| Price TargetConsensus 12-month target | $42.00 | $130.00 | $33.50 | $60.50 |
| # AnalystsCovering analysts | 8 | 14 | 12 | 12 |
| Dividend YieldAnnual dividend ÷ price | +5.7% | +7.0% | +100.0% | +6.9% |
| Dividend StreakConsecutive years of raises | 1 | 1 | 1 | 0 |
| Dividend / ShareAnnual DPS | $1873.90 | $7302.65 | $484767.98 | $4146.37 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | 0.0% | +0.0% |
BMA leads in 2 of 6 categories (Profitability & Efficiency, Total Returns). BSAC leads in 2 (Risk & Volatility, Analyst Outlook). 1 tied.
BCH vs BMA vs BSAC vs GGAL: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is BCH or BMA or BSAC or GGAL a better buy right now?
For growth investors, Banco Santander-Chile (BSAC) is the stronger pick with -5.
0% revenue growth year-over-year, versus -43. 1% for Banco de Chile (BCH). Banco Santander-Chile (BSAC) offers the better valuation at 0. 0x trailing P/E (0. 0x forward), making it the more compelling value choice. Analysts rate Banco de Chile (BCH) a "Buy" — based on 8 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — BCH or BMA or BSAC or GGAL?
On trailing P/E, Banco Santander-Chile (BSAC) is the cheapest at 0.
0x versus Banco Macro S. A. at 20. 4x. On forward P/E, Grupo Financiero Galicia S. A. is actually cheaper at 0. 0x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Grupo Financiero Galicia S. A. wins at 0. 00x versus Banco de Chile's 0. 00x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — BCH or BMA or BSAC or GGAL?
Over the past 5 years, Banco Macro S.
A. (BMA) delivered a total return of +520. 7%, compared to +54. 5% for Banco Santander-Chile (BSAC). Over 10 years, the gap is even starker: BCH returned +154. 4% versus BMA's +48. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — BCH or BMA or BSAC or GGAL?
By beta (market sensitivity over 5 years), Banco Santander-Chile (BSAC) is the lower-risk stock at 0.
94β versus Banco Macro S. A. 's 1. 76β — meaning BMA is approximately 86% more volatile than BSAC relative to the S&P 500. On balance sheet safety, Banco Macro S. A. (BMA) carries a lower debt/equity ratio of 11% versus 3% for Banco Santander-Chile — giving it more financial flexibility in a downturn.
05Which is growing faster — BCH or BMA or BSAC or GGAL?
By revenue growth (latest reported year), Banco Santander-Chile (BSAC) is pulling ahead at -5.
0% versus -43. 1% for Banco de Chile (BCH). On earnings-per-share growth, the picture is similar: Banco Santander-Chile grew EPS 492. 6% year-over-year, compared to -44. 6% for Banco Macro S. A.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — BCH or BMA or BSAC or GGAL?
Banco de Chile (BCH) is the more profitable company, earning 45.
1% net margin versus 5. 0% for Banco Macro S. A. — meaning it keeps 45. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: BCH leads at 100. 0% versus 5. 6% for BMA. At the gross margin level — before operating expenses — BCH leads at 100. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is BCH or BMA or BSAC or GGAL more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Grupo Financiero Galicia S. A. (GGAL) is the more undervalued stock at a PEG of 0. 00x versus Banco de Chile's 0. 00x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Grupo Financiero Galicia S. A. (GGAL) trades at 0. 0x forward P/E versus 0. 0x for Banco de Chile — 0. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for BMA: 73. 6% to $130. 00.
08Which pays a better dividend — BCH or BMA or BSAC or GGAL?
All stocks in this comparison pay dividends.
Banco Santander-Chile (BSAC) offers the highest yield at 100. 0%, versus 5. 7% for Banco de Chile (BCH).
09Is BCH or BMA or BSAC or GGAL better for a retirement portfolio?
For long-horizon retirement investors, Banco de Chile (BCH) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
95), 5. 7% yield, +154. 4% 10Y return). Banco Macro S. A. (BMA) carries a higher beta of 1. 76 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (BCH: +154. 4%, BMA: +48. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between BCH and BMA and BSAC and GGAL?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: BCH is a mid-cap deep-value stock; BMA is a small-cap income-oriented stock; BSAC is a mid-cap deep-value stock; GGAL is a small-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.